Picture of Sarcopenia 2013: where are we now? An update on aetiology, diagnosis and management

Sarcopenia 2013: where are we now? An update on aetiology, diagnosis and management

Sarcopenia 2013: Where are we now? An update on aetiology, diagnosis and management 9th July 2013 Congress Centre London

Sarcopenia 2013:

Where are we now? 
An update on aetiology, diagnosis and management

Conference theme

This one day accredited conference will provide a clinical and research update on the important new geriatric syndrome of sarcopenia.

Sarcopenia is the loss of skeletal muscle mass and function with advancing age and there is increasing recognition that it is central to frailty, disability, morbidity and mortality in older people as well as increasing use of health and social care.

It is the focus of intense research activity both in terms of understanding aetiology and developing interventions and there has been considerable recent progress in how sarcopenia should be defined. Yet to date, it is clear that recognition of sarcopenia in the clinical setting lags behind.

 This conference aims to provide clinicians and researchers with an update on recent developments in understanding the aetiology of sarcopenia together with practical approaches for its diagnosis and management in clinical practice. 

Opportunity to exchange knowledge and share experiences will be of key importance and emphasis will be placed on encouraging new areas of research and young researchers

 

Abstract Submission

The organizing committee at Medineo is pleased to invite you to submit abstracts for a poster presentation at our Sarcopenia 2013 conference (Posters on previously presented work are welcome). Abstracts will be selected on a "first come first serve" basis. Deadline for abstract submission is the 31st of May 2013.

All abstracts must be submitted and presented in English and should not be longer than 300 words. Enter the full name of your abstract exactly as it appears in your abstract document. This will be used for printing in the final programme. Author's, whose abstracts are accepted, must attend the meeting and present in person. Abstracts are to be presented as a poster. The size of the poster should be 90 x 120 cm. Ideally, each poster will be self-explanatory, but there will be various sessions where presenting authors are expected to be available near their poster to answer questions and engage in discussions.
All accepted abstracts will be printed in the meeting abstract book. This book will be distributed to all participants at the meeting and is included in the registration fee. For more information PLEASE CLICK HERE

 

Chaired by:

Professor Avan Aihie Sayer 
MRC Clinical Scientist and Professor of Geriatric Medicine. The University of Southampton

Chairman's welcome and presentation on: Overview - why is sarcopenia important?

 

Speakers & topics:

Prof. Malcolm Jackson 
Head, Institute of Ageing and Chronic Disease. Director, MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool

Biological mechanisms – what is the role of oxidative damage and denervation?

Prof. Doug Turnbull 
Professor of Neurology, Newcastle University

Biological mechanisms – is mitochondrial dysfunction involved?

Dr. Carolyn Greig: 
Senior Lecturer in Nutrition and Ageing, University of Birmingham

Treating sarcopenia – where are we with exercise interventions?

Dr. Sian Robinson  
Principal Research Fellow, MRC Lifecourse Epidemiology Unit, University of Southampton 

Treating sarcopenia – where are we with diet interventions?

Professor Paul Greenhaff 
MRC/Arthritis Research UK Centre for Musculoskeletal Ageing Research,
Metabolic and Molecular Physiology Research Group,School of Biomedical Sciences,
University of Nottingham Medical School, Queen's Medical Centre, Nottingham

Improving Muscle Mass and Function in Older Adults: Understanding the Mechanisms of Sarcopenia

Professor Finbarr C Martin 
Consultant Geriatrician at Guys and St Thomas' NHS Trust Professor of Medical Gerontology, King's College London

Towards a consensus definition of sarcopenia in clinical practice and research

Professor Marion E T McMurdo 

Treating sarcopenia – where are we with drug treatment?

 

 

 

 

Sarcopenia 2013:

Where are we now? 
An update on aetiology, diagnosis and management

Conference theme

This one day accredited conference will provide a clinical and research update on the important new geriatric syndrome of sarcopenia.

Sarcopenia is the loss of skeletal muscle mass and function with advancing age and there is increasing recognition that it is central to frailty, disability, morbidity and mortality in older people as well as increasing use of health and social care.

It is the focus of intense research activity both in terms of understanding aetiology and developing interventions and there has been considerable recent progress in how sarcopenia should be defined. Yet to date, it is clear that recognition of sarcopenia in the clinical setting lags behind.

 This conference aims to provide clinicians and researchers with an update on recent developments in understanding the aetiology of sarcopenia together with practical approaches for its diagnosis and management in clinical practice. 

Opportunity to exchange knowledge and share experiences will be of key importance and emphasis will be placed on encouraging new areas of research and young researchers

 

Abstract Submission

The organizing committee at Medineo is pleased to invite you to submit abstracts for a poster presentation at our Sarcopenia 2013 conference (Posters on previously presented work are welcome). Abstracts will be selected on a "first come first serve" basis. Deadline for abstract submission is the 31st of May 2013.

All abstracts must be submitted and presented in English and should not be longer than 300 words. Enter the full name of your abstract exactly as it appears in your abstract document. This will be used for printing in the final programme. Author's, whose abstracts are accepted, must attend the meeting and present in person. Abstracts are to be presented as a poster. The size of the poster should be 90 x 120 cm. Ideally, each poster will be self-explanatory, but there will be various sessions where presenting authors are expected to be available near their poster to answer questions and engage in discussions.
All accepted abstracts will be printed in the meeting abstract book. This book will be distributed to all participants at the meeting and is included in the registration fee. For more information PLEASE CLICK HERE

 

Chaired by:

Professor Avan Aihie Sayer 
MRC Clinical Scientist and Professor of Geriatric Medicine. The University of Southampton

Chairman's welcome and presentation on: Overview - why is sarcopenia important?

 

Speakers & topics:

Prof. Malcolm Jackson 
Head, Institute of Ageing and Chronic Disease. Director, MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool

Biological mechanisms – what is the role of oxidative damage and denervation?

Prof. Doug Turnbull 
Professor of Neurology, Newcastle University

Biological mechanisms – is mitochondrial dysfunction involved?

Dr. Carolyn Greig: 
Senior Lecturer in Nutrition and Ageing, University of Birmingham

Treating sarcopenia – where are we with exercise interventions?

Dr. Sian Robinson  
Principal Research Fellow, MRC Lifecourse Epidemiology Unit, University of Southampton 

Treating sarcopenia – where are we with diet interventions?

Professor Paul Greenhaff 
MRC/Arthritis Research UK Centre for Musculoskeletal Ageing Research,
Metabolic and Molecular Physiology Research Group,School of Biomedical Sciences,
University of Nottingham Medical School, Queen's Medical Centre, Nottingham

Improving Muscle Mass and Function in Older Adults: Understanding the Mechanisms of Sarcopenia

Professor Finbarr C Martin 
Consultant Geriatrician at Guys and St Thomas' NHS Trust Professor of Medical Gerontology, King's College London

Towards a consensus definition of sarcopenia in clinical practice and research

Professor Marion E T McMurdo 

Treating sarcopenia – where are we with drug treatment?

 

 

 

 

Please provide the delegate details in the above form, click "Add to cart" followed by "Checkout". If you wish to add another delegate, please click "Add a Delegate" first, complete the delegate details in above form and then "Add to cart" followed by "Checkout".

€0.00